A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HE / hepatic encephalopathy

[Related PubMed/MEDLINE]
Total Number of Papers: 1521
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HE  (>> Co-occurring Abbreviation)
Long Form:   hepatic encephalopathy
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A meta-analysis of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy. CENTRAL, CI, CINAHL, LILACS, MHE, MRS, NHE, OHE
2020 Acute Hepatic Failure and Nutrition. ALF
2020 Amelioration of thioacetamide-induced hepatic encephalopathy in rats by low-dose gamma irradiation. alpha-SMA, ALT, AST, GPx, IL-1beta, LDR, MDA, TAA, TNF-alpha
2020 BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats. ALB, ALT, AST, BBD, BMDMs, Iba1, IL-6, LPS, TAA, TBA, TBIL, TNF-alpha, TP
2020 Early Hybrid Extracorporeal Therapies in Pediatric Acute Liver Failure of Unknown Etiology. ---
2020 Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials. ACLF, ALF, ECLS, RCTs
2020 Hepatic Encephalopathy and Nutrition Influences: A Narrative Review. ---
2020 Late-Onset Hepatic Failure in Children: Risk Factors that Determine the Outcome. KCC, LOHF, PELD, PO, SR
2020 Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis. ---
10  2020 Optic nerve sheath diameter in children with acute liver failure: A prospective observational pilot study. ALF, BA, ICP, INR, ONSD
11  2020 Pro-inflammatory cytokines serve as communicating molecules between the liver and brain for hepatic encephalopathy pathogenesis and Lycium barbarum polysaccharides protection. LBP
12  2020 Relative Sarcopenia With Excess Adiposity Predicts Survival After Transjugular Intrahepatic Portosystemic Shunt Creation. HR, MELD, TIPS
13  2020 Thrombospondin-1 Exacerbates Acute Liver Failure and Hepatic Encephalopathy Pathology in Mice by Activating Transforming Growth Factor beta1. AOM, TGF-beta1, TSP-1
14  2019 A model to predict early hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt. TIPS
15  2019 A Randomized Controlled Trial Comparing Nitazoxanide Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy. CHESS, NTZ
16  2019 A validated risk model for prediction of early readmission in patients with hepatic encephalopathy. NRD
17  2019 Adherence to Recommended Inpatient Hepatic Encephalopathy Workup. ---
18  2019 Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis. OR
19  2019 Ameliorative effect of Magnesium Isoglycyrrhizinate on hepatic encephalopathy by Epirubicin. EPI, MDA, MI, SOD
20  2019 Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis. ---
21  2019 Ammonia-induced mitochondrial impairment is intensified by manganese co-exposure: relevance to the management of subclinical hepatic encephalopathy and cirrhosis-associated brain injury. Mn
22  2019 An E-Nose for the Monitoring of Severe Liver Impairment: A Preliminary Study. WS
23  2019 Application of tabu search-based Bayesian networks in exploring related factors of liver cirrhosis complicated with hepatic encephalopathy and disease identification. BNs
24  2019 Artificial liver support system therapy in acute-on-chronic hepatitis B liver failure: Classification and regression tree analysis. ALSS, CART, HBV-ACLF, PT, TBIL
25  2019 Associated vitamin D deficiency is a risk factor for the complication of HCV-related liver cirrhosis including hepatic encephalopathy and spontaneous bacterial peritonitis. HCV, ROC, SBP
26  2019 Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis. CIs, PPIs
27  2019 Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization. ALB, AUC, OR
28  2019 Behavioral, Neurochemical and Brain Oscillation Abnormalities in an Experimental Model of Acute Liver Failure. ALF, OFT
29  2019 Brain Edema in Chronic Hepatic Encephalopathy. MRI
30  2019 Brain mitochondria as potential therapeutic targets for managing hepatic encephalopathy. CNS
31  2019 Calcium-dependent kinases in the brain have site-specific associations with locomotion and rearing impairments in rats with bile duct ligation. BDL
32  2019 Cerebellar inhibition in hepatic encephalopathy. CBI, CFF, SARA
33  2019 Cerebral water content mapping in cirrhosis patients with and without manifest HE. MRI, SnPM
34  2019 cGMP signaling pathway in hepatic encephalopathy neuroinflammation and cognition. cGMP, NO, PKG
35  2019 Characteristics, Risk Factors, and Adverse Outcomes of Hyperkalemia in Acute-on-Chronic Liver Failure Patients. ACLF, AKI, CLIF-SOFA, INR, MELD, TBIL
36  2019 Characterization of Oxidative Stress and Ammonia According to the Different Grades of Hepatic Encephalopathy. CLD, HV, MDA, OxS
37  2019 Chemical exchange saturation transfer imaging in hepatic encephalopathy. APTw, CEST, CFF
38  2019 Chinese guidelines on management of hepatic encephalopathy in cirrhosis. MHE
39  2019 Choosing Wisely Canada-Top Five List in Hepatology: Official Position Statement of the Canadian Association for the Study of the Liver (CASL) and Choosing Wisely Canada (CWC). CASL, CDDW, CT, CWC, MRI
40  2019 Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Created with Expanded Polytetrafluoroethylene-Covered Stent-Grafts: 8-mm Versus 10-mm. TIPS
41  2019 Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic Encephalopathy. CHE, HRQoL, MHE
42  2019 Cognitive impairment after liver transplantation: residual hepatic encephalopathy or posttransplant encephalopathy? LT, PLTE, RHE
43  2019 Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy. NNT, RD
44  2019 Comparative accuracy and precision of two commercial laboratory analyzers for the quantification of ammonia in cerebrospinal fluid. CSF
45  2019 Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis. OR, PrI, SUCRA
46  2019 Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone and combined with embolisation for the management of cardiofundal varices: a retrospective study. TIPS
47  2019 Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study. CEPS, PaHT
48  2019 Diabetes mellitus increases the risk of hepatic encephalopathy after a transjugular intrahepatic portosystemic shunt in cirrhotic patients. DM, TIPS
49  2019 Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis. ---
50  2019 Early detection of hepatic encephalopathy after transjugular intrahepatic portsystemic shunt using multiparametric magnetic resonance with spectroscopy. mI, NAA, TIPS
51  2019 Effect of L-carnitine on liver enzymes and biochemical factors in hepatic encephalopathy: A systematic review and meta-analysis. AST, BUN, Cr
52  2019 Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese. HCC
53  2019 Elevated circulating TGFbeta1 during acute liver failure activates TGFbetaR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in mice. anti-TGFbeta1, AOM, CX3CL1, TGF-beta1, TGFbetaR2, TNF-alpha
54  2019 Emergency Transjugular Intrahepatic Portosystemic Shunt: an Effective and Safe Treatment for Uncontrolled Variceal Bleeding. LT, TIPS, VB
55  2019 Establishment and evaluation of a model for predicting 3-month mortality in Chinese patients with hepatic encephalopathy. AUC, CTP, HRS, MELD, RBC, ROC, TBIL
56  2019 Expert insights: The potential role of the gut microbiome-bile acid-brain axis in the development and progression of Alzheimer's disease and hepatic encephalopathy. AD, BA
57  2019 Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial. AMP, FMT, LBP, MELD, SOC
58  2019 Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. CI, LFI, sHRs
59  2019 Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated With Poor Patient-Reported Outcomes in Cirrhosis. ADLs, CI, HRQoL, ICT, IQR, MELD-Na, OR, PROs, PSQI
60  2019 Functional Network-Based Statistics Reveal Abnormal Resting-State Functional Connectivity in Minimal Hepatic Encephalopathy. FC, MHE, PHES
61  2019 GABA-ergic tone hypothesis in hepatic encephalopathy - Revisited. CFF, MEP-RC, SICI and LICI
62  2019 Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). AISF
63  2019 Hepatic Encephalopathy Aggravated by Systemic Inflammation. HCV, IL
64  2019 Hepatic Encephalopathy and Sarcopenia: Two Faces of the Same Metabolic Alteration. ---
65  2019 Hepatic Encephalopathy Challenges, Burden, and Diagnostic and Therapeutic Approach. ---
66  2019 Hepatic Encephalopathy in Children With Acute Liver Failure: Utility of Serum Neuromarkers. PALF
67  2019 Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology. ---
68  2019 Hepatic encephalopathy is linked to alterations of autophagic flux in astrocytes. TGM2
69  2019 Hepatic Encephalopathy Is Reversible in the Long Term After Liver Transplantation. HRQoL, IQR, LT, PHES, RBANS, TS
70  2019 Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles. MHE, WHC
71  2019 Hepatic encephalopathy: Lessons from preclinical studies. ---
72  2019 How to Design a Multicenter Clinical Trial in Hepatic Encephalopathy. RCTs
73  2019 Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues. HRQoL
74  2019 Impaired brain glymphatic flow in experimental hepatic encephalopathy. AQP4, BDL
75  2019 Implications of Manganese in Chronic Acquired Hepatocerebral Degeneration. CAHD, Mn
76  2019 Incidence of and Risk Factors for Hepatic Encephalopathy in a Population-Based Cohort of Americans With Cirrhosis. aHR, CI, GABA, IQR, PPIs
77  2019 Increasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient Sample. ALF
78  2019 Influence of proton pump inhibitors on microbiota in chronic liver disease patients. PPIs, PSM, SBP
79  2019 International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy. INR, MELD, OR
80  2019 Is sarcopenia associated with hepatic encephalopathy in liver cirrhosis? A systematic review and meta-analysis. CI, OR
81  2019 Kinetic deterioration of short memory in rat with acute hepatic encephalopathy: Involvement of astroglial and neuronal dysfunctions. DRN, GFAP, TAA
82  2019 L-Ornithine L-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses. LOLA, MHE, OHE, RCTs, TIPSS
83  2019 L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle. HRQoL, LOLA
84  2019 Limited performance of subjective global assessment compared to computed tomography-determined sarcopenia in predicting adverse clinical outcomes in patients with cirrhosis. SGA, SMI
85  2019 Long-Term Effect of Rifaximin with and without Lactulose on the Active Bacterial Assemblages in the Proximal Small Bowel and Faeces in Patients with Minimal Hepatic Encephalopathy. MHE
86  2019 Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience. CI, TIPS
87  2019 Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence. ---
88  2019 Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft. TIPS
89  2019 Longitudinal neurometabolic changes in the hippocampus of a rat model of chronic hepatic encephalopathy. BDL
90  2019 Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated? DAAs, HCC, HCV
91  2019 MetaboRank: network-based recommendation system to interpret and enrich metabolomics results. ---
92  2019 Minimal/Covert Hepatic Encephalopathy - Impact of Comorbid Conditions. ---
93  2019 Modulation of sphingosine-1-phosphate receptor by FTY720 contributes in improvement of hepatic encephalopathy induced by bile duct ligation. BDL, FSL, RRP
94  2019 Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis. TIPS
95  2019 Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis. MHE
96  2019 Neurocognitive impairment is associated with erectile dysfunction in cirrhotic patients. CFF, ED, MHE, PHES
97  2019 Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant. FMT, GABA, GF
98  2019 Neurological Complications Occurring After Liver Transplantation: Role of Risk Factors, Hepatic Encephalopathy, and Acute (on Chronic) Brain Injury. ICU, LT
99  2019 Neurological Recovery After Recovery From Acute Liver Failure: Is it Complete? ALF, LT
100  2019 Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations. ALD, CKD, HCC, NAFLD, OSA, VH